Alcan to Realign its Pharmaceutical Plastic Packaging Operations

Alcan has announced today that it plans to close its Centralia, Illinois plastic packaging operation as part of an overall optimization of its Plastics Americas pharmaceutical packaging network.

"Alcan regularly reviews its portfolio to ensure the competitiveness and long-term viability of each of its businesses," said Christel Bories, President and Chief Executive Officer, Alcan Packaging. "This alignment of our plastics manufacturing network will consolidate our strengths towards the creation of centers of excellence within our other plants," she added.

Alcan Packaging Centralia, which produces packaging for the pharmaceutical and personal care markets, will close by March 1, 2006. The production from Centralia would be transferred to other Alcan Packaging plastics plants in North America.

"In an ongoing effort to develop our leadership position in the pharmaceutical market, we continually strive to optimize our capabilities and product offering to deliver the best value to our customers," said Michael Rubenstein, President, Alcan Global Pharmaceutical Packaging. "As we have always done, we will move forward with care and respect for all affected employees," he added.

The closure will affect all 221 employees. Alcan has begun discussions with the unions and other employee representatives. A plan will be developed to assist employees through a variety of support programs.

http://www.alcan.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.